You are here: Home » PTI Stories » National » News
Business Standard

R'sthan to come up with 'olive tea' manufacturing plant

Press Trust of India  |  Jaipur 

An olive tea manufacturing plant is soon going to come up in Bassi village near here as the Rajasthan government has signed a pact with a city-based private partner.

We have signed an agreement with a private partner to manufacture olive tea.

The plant will soon be operational in Bassi village near Jaipur, Principal Secretary (Agriculture and Horticulture), Neelkamal Darbari told PTI.

Director (Agriculture) Ambrish Kumar said that the MoU has been signed for next five years and if it is profitable the state government will take 10 per cent of the earned revenue.

Elaborating further about the project, Chief Operating Officer of Rajasthan Olive Cultivation Limited, Yogesh Kumar Verma said that parts of three farms including in Jhunjhunu, Jaipur and Jalore have been given to the partner firm for collecting olive leaves.

Seventy five per cent of the farm will be with the partner and 25 per cent will be used by the state government for research and development activities.

The small-scale plant will initially produce nearly 50kg tea on daily basis. The firm has hired tea tasters as well.

Under the MoU, the partner company will maintain the farms and manage its expenses, Verma added.

Though olive team market is in nascent stages in India, its international demand is soaring due to its health benefits and its anti-oxidant rich nature.

Verma said that olive tea is 3 per cent healthier than the normal green tea.

An international brand sells one sachet of olive tea at Rs 28 and its box at Rs 508, he added.

Apart from producing olive tea, the state government is also looking forward to extract oleic acid from olive leaves, which is a major component of most of the medicines used for treating heart ailments.

Most of the medicines used in treat heart diseases have oleic acid as one of the components.

"If we are able to extract it, it will open further avenues in pharmaceutical sector," Verma said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, January 16 2017. 16:48 IST